NeoPharm Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
20,138
25,603
35,965
42,369
53,634
Cost of Goods Sold (COGS) incl. D&A
5,467
7,213
9,933
10,896
13,855
Gross Income
14,671
18,390
26,032
31,473
39,779
SG&A Expense
12,480
13,375
19,762
21,834
25,724
EBIT
2,144
4,998
6,251
9,639
14,055
Unusual Expense
1,031
1,207
1,688
32
40
Non Operating Income/Expense
551
320
546
518
486
Interest Expense
11
8
1
-
-
Pretax Income
1,948
3,720
4,322
9,439
14,032
Income Tax
53
1,152
915
1,696
2,472
Consolidated Net Income
1,895
2,568
3,407
7,742
11,559
Net Income
1,895
2,568
3,407
7,742
11,559
Net Income After Extraordinaries
1,895
2,568
3,407
7,742
11,559
Net Income Available to Common
1,895
2,568
3,407
7,742
11,559
EPS (Basic)
258.00
361.00
482.00
1,094.00
1,634.00
Basic Shares Outstanding
7
7
7
7
7
EPS (Diluted)
257.77
361.40
481.61
1,094.42
1,616.87
Diluted Shares Outstanding
7
7
7
7
7
EBITDA
3,119
5,927
7,180
10,471
14,850
Other Operating Expense
-
48
17
18
-
Non-Operating Interest Income
296
257
305
286
423
About NeoPharm Co.
View Profile
